Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryMIM auto-contouring software that uses machine learning to generate anatomical contours for trained clinical users to review and edit.
Cancer centers already using MIM workflows or evaluating vendor-neutral auto-segmentation that can be commissioned inside radiation oncology QA processes.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating MIM Contour ProtegeAI as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Confirm the exact FDA 510(k), product version, supported modality, structure set, intended use, and deployment geography because auto-segmentation claims vary by release. |
|---|---|
| Privacy | Review MIM workflow hosting, local or cloud deployment, DICOM and PHI handling, support access, retention, security controls, and contractual data-use language. |
| Evidence | Evaluate validation by anatomy and cancer site, local scanner performance, contour edit time, false contour risk, plan-quality effects, and physician acceptance. |
| Workflow | Best deployed with radiation oncologist review, dosimetry editing, physicist commissioning, structured exception handling, and documented fallback to manual contouring. |
MIM Software announced FDA-cleared Contour ProtegeAI model updates for radiation oncology segmentation, additional structures, molecular radiotherapy enhancements, and flexible workflow implementation; FDA summaries state that automatically generated contours must be reviewed and edited as needed by trained users.
Not for: Unreviewed contour acceptance, unsupported anatomy or modality, or assuming older Contour ProtegeAI claims apply to the currently licensed version.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.